DoD Peer Reviewed Alzheimer's, Convergence Science Research Award

The summary for the DoD Peer Reviewed Alzheimer's, Convergence Science Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

DoD Peer Reviewed Alzheimer's, Convergence Science Research Award: The intent of the FY19 PRARP CSRA is to support innovative or novel efforts to generate research resources, tools, or research efforts for researchers and/or practitioners in health sciences related to the PRARP's mission (see Section II.A, Program Description). The proposed work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the PRARP's mission and vision. The research innovations for the FY19 PRARP CSRA are expected to benefit the military, Veteran, and civilian communities. FY19 PRARP CSRA applications should be Innovation- and Impact-based. The FY19 PRARP CSRA offers two levels of funding. Funding Level I is intended to support early-career investigators within 3 years of their first independent faculty position, from any field or discipline. Note that Funding Level I applications will be required to include an Eligibility Statement (Attachment 6) in order to verify the eligibility of the individual named as the Principal Investigator (PI) for this award. Funding Level II is intended to support PIs at or above the level of assistant professor (or equivalent) from any field or discipline. Study teams are expected to demonstrate relevant expertise in both TBI and AD/ADRD.